Skip to main content
TipRanks
Go Ultimate75% OFF

Ralph Snodgrass Insider Profile

4 Followers

Ralph Snodgrass, PRES./CHIEF SCIENTIFIC OFFICER at VistaGen Therapeutics, holds 98.86K shares in VistaGen Therapeutics (Ticker: VTGN).

Ralph Snodgrass's Trading History

VTGN
VistaGen Therapeutics
Jan 03, 2022PRES./CHIEF SCIENTIFIC OFFICERUninformative Buy5.98K$16.11K
VTGN
Insider Shares: 98.86K (0.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 03, 2022Uninformative Buy$5.98K3,623$1.65―
Sep 03, 2021Uninformative Sell$0.00740$0.00―
Sep 03, 2021Uninformative Buy$0.001,111$0.00―
Aug 18, 2021Informative Buy$10.24K3,750$2.73-91.50%
Jul 02, 2021Uninformative Buy$6.58K3,391$1.94―

You May Also Like

Ralph Snodgrass insider profile FAQ

What is the percentage of profitable transactions made by Ralph Snodgrass?
The percentage of profitable transactions made by Ralph Snodgrass is 50%.
What is the average return per transaction made by Ralph Snodgrass?
The average return per transaction made by Ralph Snodgrass is 12.40%.
What stocks does Ralph Snodgrass hold?
Ralph Snodgrass holds: VTGN stocks.
What was Ralph Snodgrass’s latest transaction?
Ralph Snodgrass’s latest transaction was an Uninformative Buy of $5.98K.
What was Ralph Snodgrass's most profitable transaction?
Ralph Snodgrass’s most profitable transaction was an Informative Buy of VTGN stock on November 21, 2019. The return on the trade was 116.30%.
What is Ralph Snodgrass's role in VistaGen Therapeutics?
Ralph Snodgrass's role in VistaGen Therapeutics is PRES./CHIEF SCIENTIFIC OFFICER.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.